Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chubb
Novartis
US Army
Fish and Richardson
Express Scripts
Farmers Insurance
Covington
Julphar
US Department of Justice

Generated: October 20, 2017

DrugPatentWatch Database Preview

DOXEPIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Doxepin Hydrochloride, and when can generic versions of Doxepin Hydrochloride launch?

Doxepin Hydrochloride is a drug marketed by Sun Pharm Inds, Par Pharm, Purepac Pharm, Teva Pharms, Wockhardt, Silarx, Pharm Assoc, Sandoz, Watson Labs, Quantum Pharmics, Mylan Pharms Inc, Actavis Elizabeth, Dava Pharms Inc, Amneal Pharms Co, New River, and Watson Labs Teva. and is included in fifty-six NDAs.

The generic ingredient in DOXEPIN HYDROCHLORIDE is doxepin hydrochloride. There are seven drug master file entries for this compound. Thirty suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the doxepin hydrochloride profile page.

Summary for Tradename: DOXEPIN HYDROCHLORIDE

US Patents:0
Applicants:16
NDAs:56
Suppliers / Packagers: see list26
Bulk Api Vendors: see list42
Clinical Trials: see list2,296
Patent Applications: see list1,000
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXEPIN HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: DOXEPIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL072375-001Mar 15, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL071562-001Mar 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Dava Pharms Inc
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL071685-001Jan 5, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Co
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL207482-002Jun 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL071485-001Apr 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL072986-001Mar 29, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-007Apr 13, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL071654-001Feb 18, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL071763-001Feb 9, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DOXEPIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
New River
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL016987-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
US Department of Justice
US Army
Cerilliant
Cantor Fitzgerald
Teva
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot